Par Drugs and Bonus History From 2019 to 2024
Warning: Undefined variable $country in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/snippet/page_share-bonus-history.php on line 48
Warning: Undefined variable $divCurFinanH3 in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/snippet/page_share-bonus-history.php on line 277
Warning: Undefined variable $divPreFinanH3 in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/snippet/page_share-bonus-history.php on line 277
Warning: Undefined variable $divCurCalenH3 in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/snippet/page_share-bonus-history.php on line 277
Warning: Undefined variable $divPreCalenH3 in /usr/local/lsws/wordpress/wp-content/themes/Extra-child/snippet/page_share-bonus-history.php on line 277
Par Drugs and Chemicals Limited | |||
 | Symbol: PAR | ||
| Price: ₹209.15 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
The most recent bonus share given by Par Drugs and occurred 3 years ago with ex-bonus date of Tue, 27 Apr 2021. Par Drugs and has given bonus 1 times in the past, you can find its complete bonus history in below table.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Par Drugs and Bonus History Table From 2019 to 2024
| Ex-bonus Date | Ratio | Summary |
|---|---|---|
| 27-Apr-2021 | 1:1 | 1 Bonus Share on 1 |
How Many Times Par Drugs and Have Issued Bonus Share?
In the past 5 years, Par Drugs and shares have issued a bonus 1 times. If you had purchased 1 share in 2019, then by 2024, after the 1 bonus issue, your holding would have increased from 1 share to 2 shares.
For more insights into Par Drugs and Chemicals Limited, explore these additional resources:-- Par Drugs and Share Price History
- Par Drugs and Price Target Tomorrow
- Par Drugs and Price Long Term Target
- Par Drugs and Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
